Loading organizations...
Loading organizations...
Biopharmaceutical company developing drugs for liver and gastrointestinal d
HighTide Therapeutics has raised $107.0M across 1 funding round.
HighTide Therapeutics has raised $107.0M in total across 1 funding round.
HighTide Therapeutics has raised $107.0M in total across 1 funding round.
HighTide Therapeutics's investors include TCM Healthcare Fund, Yuthai Fund.
HighTide Therapeutics has raised $107.0M across 1 funding round. Most recently, it raised $107.0M Series C in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 6, 2023 | $107.0M Series C | TCM Healthcare Fund | Yuthai Fund |